Search global stocks & ETFs...Ctrl K
Learn Mode
PODD
Stock Profile
08-05
Recommended Metric
Score Card
Explore Scores Tab
4.14
Good
Valuation Score
Key Score
5.00
Very Good
Management
3.00
Average
Growth
2.00
Bad
Profitability
2.00
Bad
Fin. Health
5.00
Very Good
Dividends
--
--
Analyst
3.00
Average
Insider Transactions
Explore Insider Tab ›Buy Transactions
Sell Transactions
Peers
Select stocks to compare
Price Targets & Ratings
View Analysis
1-year price targets, ending May 11, 2027
Current
$149.19
Baseline
High
$420.00
▲
181.52%
Avg
$270.07
▲
81.02%
Low
$176.75
▲
18.47%
Analyst Ratings based on 34 Analysts
Strong Buy
1235%
Buy
1853%
Hold
412%
Sell
000%
Strong Sell
000%
Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. The company is headquartered in Acton, Massachusetts and currently employs 5,400 full-time employees. The company went IPO on 2007-05-15. The company is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. The company also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.Read More
Stock News
View All Updates
News100%Bullish
Is Insulet Corporation (PODD) A Good Stock To Buy Now?
16hYahoo
Why Insulet (PODD) is a Top Momentum Stock for the Long-Term
23hZacks
Assessing Insulet (PODD) Valuation After New Omnipod Clinical Data And System Updates
1dYahoo
Top S&P500 movers in Tuesday's session
2dChartMill
Explore the top gainers and losers within the S&P500 index in today's session.
2dChartMill
Insulet Corporation Valuation Pressure Has Dropped Enough (Upgrade)
3dSeekingAlpha
Inspire Medical: Golden Opportunity To Monetize A Fundamentally Mispriced Selloff
4dSeekingAlpha
Insulet (PODD) Enhances Omnipod 5 System with New Target Glucose Option
4dYahoo
Reported Saturday, Insulet Presents STRIVE And EVOLUTION 3 Data At ADA Showing Omnipod 6 And Fully Closed-Loop System Improve Glucose Control Across Diabetes Types
4dBenzinga
INSULET CORP (NASDAQ:PODD) Fits the Affordable Growth Mold with Strong Momentum and Reasonable Valuation
6dChartMill
Insulet Reveals New Data Supporting Breakthrough Omnipod® 6 and Fully Closed-Loop AID Systems Designed to Improve Outcomes, Reduce Effort, and Unlock Barriers to Care
6dYahoo
Stay informed with the top movers within the S&P500 index on Friday.
6dChartMill
Which S&P500 stocks are moving on Friday?
6dChartMill
Why Is Insulet (PODD) Down 8.7% Since Last Earnings Report?
6dYahoo
Nasdaq 100 Plunges Over 3% On Rate Hike Jitters, Bitcoin's Bloodbath Worsens: Stock Market Today
6dBenzinga
Stocks making the biggest moves midday: Broadcom, Arm, Strategy, Chipotle, Quantinuum & more
1wCNBC
Dexcom buys Nutrisense; Insulet rolls out patch pump update
1wYahoo
Is Omnipod 5’s Algorithm and Libre 3 Plus Upgrade Altering The Investment Case For Insulet (PODD)?
1wYahoo
3 Reasons We’re Fans of Insulet (PODD)
1wYahoo
DexCom vs. Insulet: Which Diabetes Stock Is a Better Buy in 2026?
1wYahoo
FDA Says CDRH Is Issuing Early Alert To Notify Public Of Potentially High-Risk Insulin Pump Issue From Insulet
1wBenzinga
Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions
1wYahoo
Tandem: Upgrading To Hold On A High-Stakes Pivot Story
1wSeekingAlpha
Insulet Corporation (PODD) Presents at 46th Annual William Blair Growth Stock Conference - Slideshow
1wSeekingAlpha
Insulet Presents Next Gen Omnipod Innovations To Reduce User Effort, New Algorithm Data, And Clinical Evidence Demonstrating Improved Time In Range During ADA 86th Scientific Sessions
1wBenzinga
Insulet Corporation (PODD) Presents at 46th Annual William Blair Growth Stock Conference Transcript
1wSeekingAlpha
Tandem Diabetes Valuation: Is 1.1x Sales a Buy?
1wYahoo
Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott’s FreeStyle Libre 3 Plus Sensor
1wYahoo
How The Insulet (PODD) Investment Narrative Is Evolving After Recent Developments
1wYahoo
Insulet Announces US Rollout Of New Algorithm Enhancements For Omnipod 5 Automated Insulin Delivery System
1wBenzinga
TNDM Stock: What to Know About Tandem's 2026 Reset
1wYahoo
Insulet Corporation (PODD) Initiates Voluntary Correction For Certain Omnipod Devices
1wYahoo
Court overturns Insulet’s $59M trade secret verdict against EOFlow
1wYahoo
Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More
1wYahoo
Insulet Device Correction Puts Omnipod Safety And Valuation In Focus
1wYahoo
Discover which S&P500 stocks are making waves on Thursday.
2wChartMill
Citigroup Maintains Neutral on Insulet, Lowers Price Target to $165
2wBenzinga
PODD Stock: What a Hold Rating Says at a $163 Target
2wYahoo
BSX Stock: Don't Try To Catch The Falling Knife
2wYahoo
William Blair Initiates on Insulet (PODD) With Outperform and Says the Valuation Gap Is Hard to Justify
2wYahoo
Insulet to Participate in William Blair 46th Annual Growth Stock Conference
2wYahoo
Which S&P500 stocks are moving on Wednesday?
2wChartMill
Exploring the top movers within the S&P500 index during today's session.
2wChartMill
PODD and Omnipod 5: What's Driving Insulet's 2026 Growth
2wYahoo
Gapping S&P500 stocks in Wednesday's session
2wChartMill
Dow Jones Hit Records Above 50,600 As Oil Sinks Below $90: Stock Market Today
2wBenzinga
Stocks making the biggest moves midday: Marvell, Zscaler, United Airlines, Bath & Body Works & more
2wCNBC
These S&P500 stocks are moving in today's pre-market session
2wChartMill
Insulet recalls 7M patch pumps due to leak risk
2wYahoo
RBC Capital Reiterates Outperform on Insulet, Maintains $280 Price Target
2wBenzinga